Literature DB >> 32203420

Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.

Paul M Müller1, Juliane Rademacher1, Richard D Bagshaw2, Celina Wortmann1, Carolin Barth1, Jakobus van Unen3, Keziban M Alp1, Girolamo Giudice4, Rebecca L Eccles1, Louise E Heinrich5, Patricia Pascual-Vargas5, Marta Sanchez-Castro2, Lennart Brandenburg1, Geraldine Mbamalu2, Monika Tucholska2, Lisa Spatt1, Maciej T Czajkowski1,6, Robert-William Welke1, Sunqu Zhang2, Vivian Nguyen2, Trendelina Rrustemi1, Philipp Trnka1, Kiara Freitag1, Brett Larsen2, Oliver Popp1,6, Philipp Mertins1,6, Anne-Claude Gingras2,7, Frederick P Roth2,8,9, Karen Colwill2, Chris Bakal5, Olivier Pertz3, Tony Pawson2,7, Evangelia Petsalaki10,11, Oliver Rocks12,13.   

Abstract

Rho GTPases are central regulators of the cytoskeleton and, in humans, are controlled by 145 multidomain guanine nucleotide exchange factors (RhoGEFs) and GTPase-activating proteins (RhoGAPs). How Rho signalling patterns are established in dynamic cell spaces to control cellular morphogenesis is unclear. Through a family-wide characterization of substrate specificities, interactomes and localization, we reveal at the systems level how RhoGEFs and RhoGAPs contextualize and spatiotemporally control Rho signalling. These proteins are widely autoinhibited to allow local regulation, form complexes to jointly coordinate their networks and provide positional information for signalling. RhoGAPs are more promiscuous than RhoGEFs to confine Rho activity gradients. Our resource enabled us to uncover a multi-RhoGEF complex downstream of G-protein-coupled receptors controlling CDC42-RHOA crosstalk. Moreover, we show that integrin adhesions spatially segregate GEFs and GAPs to shape RAC1 activity zones in response to mechanical cues. This mechanism controls the protrusion and contraction dynamics fundamental to cell motility. Our systems analysis of Rho regulators is key to revealing emergent organization principles of Rho signalling.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32203420     DOI: 10.1038/s41556-020-0488-x

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  84 in total

Review 1.  Spatio-temporal Rho GTPase signaling - where are we now?

Authors:  Olivier Pertz
Journal:  J Cell Sci       Date:  2010-06-01       Impact factor: 5.285

Review 2.  Rho GTPases: biochemistry and biology.

Authors:  Aron B Jaffe; Alan Hall
Journal:  Annu Rev Cell Dev Biol       Date:  2005       Impact factor: 13.827

Review 3.  GDIs: central regulatory molecules in Rho GTPase activation.

Authors:  Céline DerMardirossian; Gary M Bokoch
Journal:  Trends Cell Biol       Date:  2005-07       Impact factor: 20.808

Review 4.  Current knowledge of the large RhoGAP family of proteins.

Authors:  Joseph Tcherkezian; Nathalie Lamarche-Vane
Journal:  Biol Cell       Date:  2007-02       Impact factor: 4.458

Review 5.  GEFs and GAPs: critical elements in the control of small G proteins.

Authors:  Johannes L Bos; Holger Rehmann; Alfred Wittinghofer
Journal:  Cell       Date:  2007-06-01       Impact factor: 41.582

Review 6.  GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors.

Authors:  Kent L Rossman; Channing J Der; John Sondek
Journal:  Nat Rev Mol Cell Biol       Date:  2005-02       Impact factor: 94.444

Review 7.  The 'invisible hand': regulation of RHO GTPases by RHOGDIs.

Authors:  Rafael Garcia-Mata; Etienne Boulter; Keith Burridge
Journal:  Nat Rev Mol Cell Biol       Date:  2011-07-22       Impact factor: 94.444

Review 8.  Catching a GEF by its tail.

Authors:  Rafael García-Mata; Keith Burridge
Journal:  Trends Cell Biol       Date:  2006-11-28       Impact factor: 20.808

Review 9.  Mammalian Rho GTPases: new insights into their functions from in vivo studies.

Authors:  Sarah J Heasman; Anne J Ridley
Journal:  Nat Rev Mol Cell Biol       Date:  2008-09       Impact factor: 94.444

Review 10.  Deregulation of Rho GTPases in cancer.

Authors:  Andrew P Porter; Alexandra Papaioannou; Angeliki Malliri
Journal:  Small GTPases       Date:  2016-04-22
View more
  48 in total

1.  Rho GTPases and the emerging role of tunneling nanotubes in physiology and disease.

Authors:  Suli Zhang; Marcelo G Kazanietz; Mariana Cooke
Journal:  Am J Physiol Cell Physiol       Date:  2020-08-26       Impact factor: 4.249

Review 2.  Kalirin as a Novel Treatment Target for Cognitive Dysfunction in Schizophrenia.

Authors:  Arne W Mould; Noura Al-Juffali; Annette von Delft; Paul E Brennan; Elizabeth M Tunbridge
Journal:  CNS Drugs       Date:  2021-12-20       Impact factor: 5.749

3.  Yersinia remodels epigenetic histone modifications in human macrophages.

Authors:  Indra Bekere; Jiabin Huang; Marie Schnapp; Maren Rudolph; Laura Berneking; Klaus Ruckdeschel; Adam Grundhoff; Thomas Günther; Nicole Fischer; Martin Aepfelbacher
Journal:  PLoS Pathog       Date:  2021-11-18       Impact factor: 6.823

Review 4.  Fine-tuning cell organelle dynamics during mitosis by small GTPases.

Authors:  Zijian Zhang; Wei Zhang; Quentin Liu
Journal:  Front Med       Date:  2022-06-27       Impact factor: 9.927

5.  SRGAP1 Controls Small Rho GTPases To Regulate Podocyte Foot Process Maintenance.

Authors:  Manuel Rogg; Jasmin I Maier; Robert Dotzauer; Nadine Artelt; Oliver Kretz; Martin Helmstädter; Ahmed Abed; Alena Sammarco; August Sigle; Dominik Sellung; Patrick Dinse; Karoline Reiche; Mako Yasuda-Yamahara; Martin L Biniossek; Gerd Walz; Martin Werner; Nicole Endlich; Oliver Schilling; Tobias B Huber; Christoph Schell
Journal:  J Am Soc Nephrol       Date:  2021-01-29       Impact factor: 10.121

6.  Single-Component Optogenetic Tools for Inducible RhoA GTPase Signaling.

Authors:  Erin E Berlew; Ivan A Kuznetsov; Keisuke Yamada; Lukasz J Bugaj; Joel D Boerckel; Brian Y Chow
Journal:  Adv Biol (Weinh)       Date:  2021-07-21

7.  A Complete Survey of RhoGDI Targets Reveals Novel Interactions with Atypical Small GTPases.

Authors:  Ana Masara Binti Ahmad Mokhtar; Samrein B M Ahmed; Nicola J Darling; Matthew Harris; Helen R Mott; Darerca Owen
Journal:  Biochemistry       Date:  2021-04-29       Impact factor: 3.162

8.  An ARHGAP25 variant links aberrant Rac1 function to early-onset skeletal fragility.

Authors:  Riikka E Mäkitie; Petra Henning; Yaming Jiu; Anders Kämpe; Konstantin Kogan; Alice Costantini; Ville-Valtteri Välimäki; Carolina Medina-Gomez; Minna Pekkinen; Isidro B Salusky; Camilla Schalin-Jäntti; Maria K Haanpää; Fernando Rivadeneira; John H Duncan Bassett; Graham R Williams; Ulf H Lerner; Renata C Pereira; Pekka Lappalainen; Outi Mäkitie
Journal:  JBMR Plus       Date:  2021-06-07

Review 9.  Progress in the therapeutic inhibition of Cdc42 signalling.

Authors:  Natasha P Murphy; Helen R Mott; Darerca Owen
Journal:  Biochem Soc Trans       Date:  2021-06-30       Impact factor: 5.407

Review 10.  Protein Hydrogels: The Swiss Army Knife for Enhanced Mechanical and Bioactive Properties of Biomaterials.

Authors:  Carla Huerta-López; Jorge Alegre-Cebollada
Journal:  Nanomaterials (Basel)       Date:  2021-06-24       Impact factor: 5.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.